Its anti-inflammatory effects limit immune-mediated tissue damage, while angiogenesis improves blood flow, delivering oxygen and nutrients to injured areas to accelerate healing
Although this has been found to be the case, it was also found that other preprocedural GI effects were observed with a higher incidence in GLP-1 RA users such as reduced gastric acidity, nausea, vomiting, dyspepsia, and abdominal distension (OR 15.1
Have you had Resilience Boost injections in the past
This remains speculative, but it could explain why some users report UTIs specifically during the first few months of treatment, during the early weeks on semaglutide when the body is adjusting most dramatically
Inflammopharmacology, Journal of Physiology - Paris, Current Pharmaceutical Design, Frontiers in Pharmacology (representative journals)
All medical information is regularly monitored, audited and updated in light of the latest scientific advancements